8 April 2026
Exdensur (depemokimab) approved in China for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) GSK plc (LSE/NYSE: GSK) today announced that China’s National Medical…
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s”) Young’s to acquire Cubitt House Young’s, the premium operator of pubs and bedrooms in London and the South…
2 April 2026
SSE plc Trading Update 2 April 2026 Ahead of the publication on 28 May 2026 of results for the full year ended 31 March…
THE MERCHANTS TRUST PLC LEI: 5299008VJFXCUD2EG312 FINAL RESULTS FOR THE YEAR ENDED 31 JANUARY 2026 The following comprises extracts from the company’s Annual Report…
Murray Income Trust PLC (“the Company”) Legal Entity Identifier (LEI): 549300IRNFGVQIQHUI13 2 April 2026 Update on Transition of Portfolio Holdings The Board of Murray Income…
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable liver cancer in EMERALD-3 Phase III trial Imfinzi plus…
B.P. Marsh & Partners Plc(“B.P. Marsh”, “the Company” or “the Group”) Follow-on equity purchase in Pantheon Specialty Group Limited (“Pantheon”) B.P. Marsh and Partners…
31 March 2026
JAMES HALSTEAD PLC (“James Halstead or the “Company”) INTERIM RESULTS FOR THE HALF-YEAR ENDED 31 DECEMBER 2025 Solid H1 trading and despite challenging markets,…